News
1h
Zacks Investment Research on MSNEsperion Therapeutics (ESPR) Reports Q1 Loss, Tops Revenue EstimatesEsperion Therapeutics (ESPR) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to earnings of $0.34 per share a year ago. These ...
NORWOOD, Mass. (AP) — NORWOOD, Mass. (AP) — Corbus Pharmaceuticals Holdings Inc. (CRBP) on Tuesday reported a loss of $17 million in its first quarter. On a per-share basis, the Norwood, Massachusetts ...
1h
Zacks Investment Research on MSNDuke Energy (DUK) Q1 Earnings and Revenues Surpass EstimatesDuke Energy (DUK) came out with quarterly earnings of $1.76 per share, beating the Zacks Consensus Estimate of $1.59 per share. This compares to earnings of $1.44 per share a year ago. These figures ...
MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — IPG Photonics Corp. (IPGP) on Tuesday reported first-quarter earnings of $3.8 million. The Marlborough, Massachusetts-based company said it had net ...
China’s tech giants Baidu and Tencent Holdings Ltd. have both emerged as major players in the artificial intelligence (AI) ...
NORTH BETHESDA, Md. (AP) — NORTH BETHESDA, Md. (AP) — Xometry Inc. (XMTR) on Tuesday reported a loss of $15.1 million in its first quarter. On a per-share basis, the North Bethesda, Maryland-based ...
2h
Zacks.com on MSNShould You Invest in the SPDR S&P Semiconductor ETF (XSD)?You should consider the SPDR S&P Semiconductor ETF (XSD), a passively managed exchange traded fund launched on 01/31/2006. An increasingly popular option among retail and institutional investors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results